HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
FRIDAY, Jan. 19, 2018 (HealthDay News) -- For adolescents with depression who declined or quickly stopped using antidepressants, a brief cognitive behavioral therapy (CBT) program is cost-effective, according to a study published online Jan. 19 in Pediatrics.
John F. Dickerson, Ph.D., from the Kaiser Permanente Center for Health Research in Portland, Ore., and colleagues randomized 212 youth with depression to treatment as usual (TAU) or TAU plus brief individual CBT. Depression-free days (DFD) and estimated quality-adjusted life-years (QALYs) were assessed as clinical outcomes. Over 12- and 24-month follow-up periods, incremental cost-effectiveness ratios (ICERs) comparing CBT with TAU were calculated.
The researchers found that over 12 months, youth randomized to CBT versus TAU had 26.8 more DFDs (P = 0.044) and 0.067 more QALYs (P = 0.044) on average. By the end of the 24-month follow-up period, the total costs were $4,976 less (P = 0.025) among youth randomized to CBT. Per DFD, the total costs were −$51 and −$115 at 12 and 24 months, respectively (ICER, −$51 [95 percent confidence interval, −$394 to $9] and −$115 [95 percent confidence interval, −$1,090 to −$6], respectively). Per QALY, the total costs were −$20,282 and −$45,792 at 12 and 24 months, respectively (ICER, −$20,282 [95 percent confidence interval, −$156,741 to $3,617] and −$45,792 [95 percent confidence interval, −$440,991 to −$2,731], respectively).
"Brief primary care CBT among youth declining antidepressant therapy is cost-effective by widely accepted standards in depression treatment," the authors write. "CBT becomes dominant over TAU over time, as revealed by a statistically significant cost offset at the end of the two-year follow-up."
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 28, 2022